BRÈVE publiée le 16/09/2024 à 18:24, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares Investors Ordinary Shares Share Buyback Numis Securities Fuller, Smith & Turner
BRÈVE publiée le 16/09/2024 à 18:24, il y a 2 années 1 mois Fuller, Smith & Turner PLC : transaction sur actions propres Rachat D'actions Investisseurs Actions Ordinaires Numis Securities Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 16/09/2024 à 18:19, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces transaction in own shares on 16/09/2024. Purchased 2,231 'A' ordinary shares at 752.00 GBp per share as part of buyback programme. Shares to be held in treasury Treasury Fuller, Smith & Turner PLC Own Shares Transaction Buyback Programme
BRÈVE publiée le 13/09/2024 à 18:26, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Share Buyback Transaction London Stock Exchange Ordinary Shares Share Buyback Numis Securities Fuller’s
BRÈVE publiée le 13/09/2024 à 18:26, il y a 2 années 1 mois Fuller, Smith & Turner PLC : opération de rachat d'actions Rachat D'actions Actions Ordinaires Numis Securities Bourse De Londres Fuller
COMMUNIQUÉ DE PRESSE publié le 13/09/2024 à 18:21, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 'A' ordinary shares as part of its share buyback program. Shares held in Treasury. Details of transactions provided London Stock Exchange Share Buyback Program Treasury Shares Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 12/09/2024 à 18:21, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller, Smith & Turner
BRÈVE publiée le 12/09/2024 à 18:21, il y a 2 années 1 mois Fuller, Smith & Turner PLC : transaction sur actions propres Actions Propres Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 12/09/2024 à 18:16, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program. Company holds 4,158,786 'A' ordinary shares in treasury London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Treasury Shares Numis Securities Limited
BRÈVE publiée le 10/09/2024 à 18:30, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Investment Fuller’s
Publié le 04/11/2026 à 18:00, il y a 8 heures 22 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 8 heures 22 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 8 heures 38 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 12 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 3 heures 22 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 7 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 4 heures 17 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 2 heures 19 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 6 heures 41 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 6 heures 57 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 7 heures 39 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 8 heures 17 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
